A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome

NCT03384420 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitochondrial Diseases
Pearson Syndrome

Interventions

BIOLOGICAL: CD34+ cells enriched with MNV-BLD

Sponsor

Minovia Therapeutics Ltd.